Jula Inrig
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Travere Therapeutics, Inc. (TVTX)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Travere Therapeutics, Inc. (TVTX) | Chief Medical Officer | $568,084 | $3,041,632 |
| 2024 | Travere Therapeutics, Inc. (TVTX) | Chief Medical Officer | $522,083 | $1,681,277 |
| 2023 | Travere Therapeutics, Inc. (TVTX) | Chief Medical Officer | $486,250 | $2,001,539 |
| 2022 | Travere Therapeutics, Inc. (TVTX) | Chief Medical Officer | $445,000 | $2,866,793 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.